Abstract
Dendritic cells are the most potent antigen-presenting cells, and are critical for the generation of an antigen-specific immune response and protective immunity. These unique features have been applied to dendritic cell-based immunization in a number of disease conditions. Our published results have demonstrated that the immunity induced by intranasal immunization with DNA-transfected dendritic cells results in reduced fungal burden, and alleviated lung tissue damage in a mouse model of pulmonary fungal infection. In this article, approaches for the preparation and characterization of DNA-transfected dendritic cells and intranasal immunization in mice are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296
Rescigno M, Winzler C, Delia D, Mutini C, Lutz M, Ricciardi-Castagnoli P (1997) Dendritic cell maturation is required for initiation of the immune response. J Leukoc Biol 61(4):415–421
Ahmed MS, Bae YS (2016) Dendritic cell-based immunotherapy for rheumatoid arthritis: from bench to bedside. Immune Netw 16(1):44–51
Constantino J, Gomes C, Falcao A, Cruz MT, Neves BM (2016) Antitumor dendritic cell-based vaccines: lessons from 20 years of clinical trials and future perspectives. Transl Res 168:74–95
Bagirova M, Allahverdiyev AM, Abamor ES, Ullah I, Cosar G, Aydogdu M, Senturk H, Ergenoglu B (2016) Overview of dendritic cell-based vaccine development for leishmaniasis. Parasite Immunol 38(11):651–662
Cockburn IA, Zavala F (2016) Dendritic cell function and antigen presentation in malaria. Curr Opin Immunol 40:1–6
Miller E, Bhardwaj N (2014) Advances in dendritic cell immunotherapies for HIV-1 infection. Expert Opin Biol Ther 14(11):1545–1549
Pyzer AR, Avigan DE, Rosenblatt J (2014) Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies. Hum Vaccin Immunother 10(11):3125–3131
Gursel DB, Schlaff CD, Boockvar JA (2012) Trials and tribulations of cancer immunotherapy: the dendritic cell vaccine shows promise in a phase I glioblastoma multiforme trial. Neurosurgery 71(6):N19–N21
Li S, Roberts S, Plebanski M, Gouillou M, Spelman T, Latour P, Jackson D, Brown L, Sparrow RL, Prince HM, Hart D, Loveland BE, Gowans EJ (2012) Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individuals. PLoS One 7(8):e39368
Curti A, Tosi P, Comoli P, Terragna C, Ferri E, Cellini C, Massaia M, D'Addio A, Giudice V, Di Bello C, Cavo M, Conte R, Gugliotta G, Baccarani M, Lemoli RM (2007) Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides. Br J Haematol 139(3):415–424
Baratelli F, Takedatsu H, Hazra S, Peebles K, Luo J, Kurimoto PS, Zeng G, Batra RK, Sharma S, Dubinett SM, Lee JM (2008) Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer. J Transl Med 6:38
Cheever MA, Higano CS (2011) PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin Cancer Res 17(11):3520–3526
Ueno K, Kinjo Y, Okubo Y, Aki K, Urai M, Kaneko Y, Shimizu K, Wang DN, Okawara A, Nara T, Ohkouchi K, Mizuguchi Y, Kawamoto S, Kamei K, Ohno H, Niki Y, Shibuya K, Miyazaki Y (2015) Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii. Infect Immun 83(4):1577–1586
Awasthi S, Cox RA (2003) Transfection of murine dendritic cell line (JAWS II) by a nonviral transfection reagent. BioTechniques 35(3):600–602, 604
Vilekar P, Awasthi V, Lagisetty P, King C, Shankar N, Awasthi S (2010) In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine. BMC Immunol 11:60
Zhu Y, Yang C, Magee DM, Cox RA (1996) Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA. Infect Immun 64(7):2695–2699
Peng T, Shubitz L, Simons J, Perrill R, Orsborn KI, Galgiani JN (2002) Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice. Infect Immun 70(7):3330–3335
Awasthi S, Awasthi V, Magee DM, Coalson JJ (2005) Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii. J Immunol 175(6):3900–3906
Awasthi S (2007) Dendritic cell-based vaccine against Coccidioides infection. Ann N Y Acad Sci 1111:269–274
Hu B, Zhang Y, Zeng Q, Han Q, Zhang L, Liu M, Li X (2014) Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes. Int J Mol Sci 15(1):1606–1624
Banerjee P, Biswas A, Biswas T (2008) Porin-incorporated liposome induces toll-like receptors 2- and 6-dependent maturation and type 1 response of dendritic cell. Int Immunol 20(12):1551–1563
Hillyer L, Whitley C, Olver A, Webster M, Steevels T, Woodward B (2008) Adoptively transferred dendritic cells restore primary cell-mediated inflammatory competence to acutely malnourished weanling mice. Am J Pathol 172(2):378–385
Guo H, Hao J, Wu C, Shi Y, Zhao XY, Fang DC (2007) A novel peptide-nucleotide dual vaccine of human telomerase reverse transcriptase induces a potent cytotoxic T-cell response in vivo. Biochem Biophys Res Commun 357(4):1090–1095
Hu Y, Li M, Lu B, Wang X, Chen C, Zhang M (2016) Corticotropin-releasing factor augments LPS-induced immune/inflammatory responses in JAWSII cells. Immunol Res 64(2):540–547
Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B (2012) A novel self-assembled nanoparticle vaccine with HIV-1 Tat49-57/HPV16 E749-57 fusion peptide and GM-CSF DNA elicits potent and prolonged CD8(+) T cell-dependent anti-tumor immunity in mice. Vaccine 30(6):1071–1082
Chan YH, Chiang MF, Tsai YC, ST S, Chen MH, Hou MS, Lin KI (2009) Absence of the transcriptional repressor blimp-1 in hematopoietic lineages reveals its role in dendritic cell homeostatic development and function. J Immunol 183(11):7039–7046
Cutler JE, Deepe GS Jr, Klein BS (2007) Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 5(1):13–28
Capilla J, Clemons KV, Stevens DA (2007) Animal models: an important tool in mycology. Med Mycol 45(8):657–684
Jiang X, Shen C, Rey-Ladino J, Yu H, Brunham RC (2008) Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect Immun 76(6):2392–2401
Tarcha EJ, Basrur V, Hung CY, Gardner MJ, Cole GT (2006) Multivalent recombinant protein vaccine against coccidioidomycosis. Infect Immun 74(10):5802–5813
Baumjohann D, Lutz MB (2006) Non-invasive imaging of dendritic cell migration in vivo. Immunobiology 211(6–8):587–597
Zhou H, Zhang D, Wang Y, Dai M, Zhang L, Liu W, Liu D, Tan H, Huang Z (2006) Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector. Biochem Biophys Res Commun 347(1):200–207
McCormick S, Santosuosso M, Small CL, Shaler CR, Zhang X, Jeyanathan M, Mu J, Takenaka S, Ngai P, Gauldie J, Wan Y, Xing Z (2008) Mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous APCs. J Immunol 181(4):2356–2367
Pham W, Kobukai S, Hotta C, Gore JC (2009) Dendritic cells: therapy and imaging. Expert Opin Biol Ther 9(5):539–564
Clemons KV, Capilla J, Stevens DA (2007) Experimental animal models of coccidioidomycosis. Ann N Y Acad Sci 1111:208–224
Dekaban GA, Hamilton AM, Fink CA, Au B, de Chickera SN, Ribot EJ, Foster PJ (2013) Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5(5):469–483
Hung CY, Hurtgen BJ, Bellecourt M, Sanderson SD, Morgan EL, Cole GT (2012) An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection. Vaccine 30(31):4681–4690
Sagar D, Foss C, El Baz R, Pomper MG, Khan ZK, Jain P (2012) Mechanisms of dendritic cell trafficking across the blood-brain barrier. J Neuroimmune Pharmacol 7(1):74–94
Wang J, Tian M, Zhang H (2011) PET molecular imaging in stem cell therapy for neurological diseases. Eur J Nucl Med Mol Imaging 38(10):1926–1938
Pham GH, Iglesias BV, Gosselin EJ (2014) Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells. Vaccine 32(40):5212–5220
Awasthi S, Magee DM (2004) Differences in expression of cell surface co-stimulatory molecules, toll-like receptor genes and secretion of IL-12 by bone marrow-derived dendritic cells from susceptible and resistant mouse strains in response to Coccidioides posadasii. Cell Immunol 231(1–2):49–55
Acknowledgments
The author acknowledges funding support from the San Antonio Area Foundation, San Antonio, TX (2003–2004) and Oklahoma Center for Advancement of Science and Technology, Oklahoma City, OK (2007–2010) for the research conducted on dendritic cell-based immunization for coccidioidomycosis. Editorial support from Ms. Kathy Kyler, Staff Editor at the University of Oklahoma Health Sciences Center, is appreciated.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Awasthi, S. (2017). Intranasal Antifungal Vaccination Using DNA-Transfected Dendritic Cells. In: Kalkum, M., Semis, M. (eds) Vaccines for Invasive Fungal Infections. Methods in Molecular Biology, vol 1625. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7104-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7104-6_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7103-9
Online ISBN: 978-1-4939-7104-6
eBook Packages: Springer Protocols